SCHEMBL645807

SCHEMBL645807

CN(C)c1ccc2cc(Br)ccc2c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
APP P05067 6/20 0.50
TERT O14746 1/20 0.50
CYP2A6 P11509 1/20 0.50
ALDH1A1 P00352 3/20 0.46
KDM4E B2RXH2 1/20 0.46
MEN1 O00255 1/20 0.46
MAPT P10636 1/20 0.46
KMT2A Q03164 1/20 0.46
NCEH1 Q6PIU2 2/20 0.46
TSHR P16473 2/20 0.43
ALOX15 P16050 1/20 0.43
HSD17B10 Q99714 1/20 0.43
BACE1 P56817 1/20 0.41
EGFR P00533 3/20 0.40
LMNA P02545 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
NPC1 O15118 1/20 0.38
NCOA1 Q15788 1/20 0.38
NCOA3 Q9Y6Q9 1/20 0.38
APAF1 O14727 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29543329 1.00 APP (0.50) APPTERTCYP2A6ALDH1A1KDM4E
SCHEMBL31457375 0.93 APP (0.48) APPTERTCYP2A6ALDH1A1KDM4E
SCHEMBL12566471 0.85 TERT (0.64) APPTERTALDH1A1KDM4EMEN1
SCHEMBL10000460 0.79 LMNA (0.45) APPTERTCYP2A6ALDH1A1KDM4E
SCHEMBL29353067 0.77 CYP2A6 (0.77) CYP2A6ALDH1A1KDM4EMEN1MAPT
SCHEMBL192166 0.77 CYP2A6 (0.77) CYP2A6ALDH1A1KDM4EMEN1MAPT
SCHEMBL5593736 0.77 TERT (0.55) TERTCYP2A6ALDH1A1KDM4EMEN1
SCHEMBL372242 0.76 TERT (0.54) APPTERTCYP2A6ALDH1A1TSHR
SCHEMBL29529426 0.76 TERT (0.54) APPTERTCYP2A6ALDH1A1TSHR
SCHEMBL29463702 0.76 TERT (0.54) APPTERTCYP2A6ALDH1A1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 43 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230144841-A1 INHIBITORS OF FIBROBLAST ACTIVATION PROTEIN Praxis Biotech LLC (US) 2023-05-11 US disclosed
US-20230144841-A1 INHIBITORS OF FIBROBLAST ACTIVATION PROTEIN Praxis Biotech LLC (US) 2023-05-11 US disclosed
US-20230144841-A1 INHIBITORS OF FIBROBLAST ACTIVATION PROTEIN Praxis Biotech LLC (US) 2023-05-11 US disclosed
US-11504364-B2 Inhibitors of fibroblast activation protein Praxis Biotech LLC (US) 2022-11-22 US disclosed
US-11279677-B2 Photochromic hydrazone switches THE TRUSTEES OF DARTMOUTH COLLEGE (US) 2022-03-22 US disclosed
EP-3898654-A2 INHIBITORS OF FIBROBLAST ACTIVATION PROTEIN Praxis Biotech LLC (US) 2021-10-27 EP disclosed
US-20200206216-A1 INHIBITORS OF FIBROBLAST ACTIVATION PROTEIN Praxis Biotech LLC 2020-07-02 US disclosed
CN-110343065-B Specific two-photon fluorescent probe of monoamine oxidase A as well as preparation method and application thereof 南京工业大学 2020-06-30 CN disclosed
WO-2020132661-A2 INHIBITORS OF FIBROBLAST ACTIVATION PROTEIN Praxis Biotech LLC (US) 2020-06-25 WO disclosed
WO-2020132661-A2 INHIBITORS OF FIBROBLAST ACTIVATION PROTEIN Praxis Biotech LLC (US) 2020-06-25 WO disclosed
US-20080293766-A1 SMALL-MOLECULE INHIBITORS OF THE ANDROGEN RECEPTOR REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2008-11-27 US disclosed
US-20080293766-A1 SMALL-MOLECULE INHIBITORS OF THE ANDROGEN RECEPTOR REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2008-11-27 US disclosed
US-20080293766-A1 SMALL-MOLECULE INHIBITORS OF THE ANDROGEN RECEPTOR REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2008-11-27 US disclosed
WO-2008128100-A1 SMALL-MOLECULE INHIBITORS OF THE ANDROGEN RECEPTOR THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2008-10-23 WO disclosed
WO-2008128100-A1 SMALL-MOLECULE INHIBITORS OF THE ANDROGEN RECEPTOR THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2008-10-23 WO disclosed
WO-2008124812-A1 PHEN-NAPHTHALENE AND PHEN-QUINOLINE DERIVATIVES AND THEIR USE FOR BINDING AND IMAGING AMYLOID PLAQUES THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) 2008-10-16 WO disclosed
WO-2007022263-A1 FLUOROGENIC PROBES FOR MEDIUM CHAIN ACYL-COA DEHYDROGENASE ( MCAD ) THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) 2007-02-22 WO disclosed
US-6867320-B2 Substituted phenylalkanoic acid derivatives and use thereof ASAHI KASEI PHARMA CORPORATION (JP) 2005-03-15 US disclosed
EP-1477472-A1 SUBSTITUTED PHENYLALKANOIC ACID DERIVATIVE AND USE THEREOF Asahi Kasei Pharma Corporation (JP) 2004-11-17 EP disclosed
US-20040044258-A1 Substituted phenylalkanoic acid derivatives and use thereof ASAHI KASEI PHARMA CORPORATION (JP) 2004-03-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230144841-A1 INHIBITORS OF FIBROBLAST ACTIVATION PROTEIN FAP, FIBP, FRS2 APP 2006/4885TERT 548/4885CYP2A6 4460/4885
US-11504364-B2 Inhibitors of fibroblast activation protein FAP, FIBP, FRS2 APP 2006/4885TERT 548/4885CYP2A6 4460/4885
US-20040044258-A1 Substituted phenylalkanoic acid derivatives and use thereof PTGER1, CYSLTR1, PTGS1 APP 2393/4885TERT 2382/4885CYP2A6 318/4885
US-20080293766-A1 SMALL-MOLECULE INHIBITORS OF THE ANDROGEN RECEPTOR AR, GNRHR, FSHR APP 2583/4885TERT 2621/4885CYP2A6 28/4885
US-11279677-B2 Photochromic hydrazone switches CRYZ, PIN1, PPOX APP 3427/4885TERT 709/4885CYP2A6 2633/4885
US-20200206216-A1 INHIBITORS OF FIBROBLAST ACTIVATION PROTEIN FAP, FIBP, FRS2 APP 2006/4885TERT 548/4885CYP2A6 4460/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.